A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression

Investigating a novel plasma biomarker's potential for identifying gut leakage.

A unique approach to anti-inflammatory Immune therapy

Next Generation monoclonal antibody therapies targeting the inhibitory FcR.

Addressing the healthcare needs of people ageing with HIV in Victoria

Identifying requirements and gaps in Victoria and influence policy for government.

Antibody mAbs to destroy infection: engineering the next generation treatments

Applying discoveries from our cancer mAb program to neutralize and destroy pathogens.

Broadly neutralising anti-HIV antibodies and Fc Receptor function

Defining the properties of anti-HIV antibodies for vaccine development and protection of pregnant women.

Developing new HIV disease progression tests

This project will develop prognostic tools to identify HIV+ persons at risk of rapid disease progression.

Discovery of new cell surface biomarkers of Th17 and Th1 cells

We are researching the cause of inflammation associated with rheumatoid arthritis.

Discovery of new treatments for myeloma and myelogenous leukemia

We are developing monoclonal antibodies against new biomakers to treat blood cancers.

FcgR Function in cellular responses to malaria parasites

Understanding how antibodies protect against malaria is crucial to vaccine development.

New approaches to the treatment of lupus

Research into an early intervention diagnostic test for Lupus, which is particularly dangerous to women.

Predicting quality and potency of monoclonal and natural antibodies

Rapid, simple and scalable assays for predicting antibody potency.

Understanding the connection between inflammation and cancer

Defining the relationship between inflammation and cancer with the aim of developing new therapies.